Patents by Inventor Ruth Katz
Ruth Katz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230220487Abstract: Methods for detecting cancer cells, or aggressive cancers, by measuring levels of cardiolipin molecules are provided. Methods of treating identified cancers are likewise provided.Type: ApplicationFiled: June 7, 2021Publication date: July 13, 2023Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMInventors: Livia S. EBERLIN, Ruth KATZ
-
Patent number: 11182901Abstract: A difference image representing intensity differences between a first medical image and a second medical image is generated. A mixture model is fitted to an intensity distribution of the difference image to identify a plurality of probability distributions which collectively model the intensity distribution. A plurality of intensity ranges is determined as a function of the plurality of probability distributions. Image data of the difference image is labeled by determining into which of the plurality of intensity ranges said labeled image data falls. This technique more accurately details changes in medical images than known systems and methods.Type: GrantFiled: June 29, 2017Date of Patent: November 23, 2021Assignee: KONINKLIJKE PHILIPS N.V.Inventors: Tamar Debora Schirman, Shelly Theodora Yehezkely, Yossi Kam, Georgy Shakirin, Frank Olaf Thiele, Ruth Katz
-
Publication number: 20210277481Abstract: The present disclosure comprises a method of detecting circular tumor cells and methods of detecting, evaluating, or staging cancer in a patient, as well as a method of monitoring treatment of cancer in a patient using the claimed method. In other embodiments, the method provides for directed to a method of determining the level of circulating tumor cells (CTCs) in a sample having blood cells from a patient by contacting a sample having blood cells from a patient.Type: ApplicationFiled: October 1, 2020Publication date: September 9, 2021Applicant: Board of Regents, The University of Texas SystemInventor: Ruth KATZ
-
Publication number: 20190188853Abstract: A system and method are provided for change detection in medical images. A difference image representing intensity differences between a first medical image and a second medical image is generated. A mixture model is fitted to an intensity distribution of the difference image to identify a plurality of probability distributions which collectively model the intensity distribution. A plurality of intensity ranges is determined as a function of the plurality of probability distributions. Image data of the difference image is labeled by determining into which of the plurality of intensity ranges said labeled image data falls. Accordingly, more accurate change detection is obtained than known systems and method.Type: ApplicationFiled: June 29, 2017Publication date: June 20, 2019Inventors: Tamar Debora Schirman, Shelly Theodora Yehezkely, Yossi Kam, Georgy Shakirin, Frank Olaf Thiele, Ruth Katz
-
Publication number: 20180127829Abstract: The present disclosure comprises a method of detecting circular tumor cells and methods of detecting, evaluating, or staging cancer in a patient, as well as a method of monitoring treatment of cancer in a patient using the claimed method. In other embodiments, the method provides for directed to a method of determining the level of circulating tumor cells (CTCs) in a sample having blood cells from a patient by contacting a sample having blood cells from a patient.Type: ApplicationFiled: December 10, 2015Publication date: May 10, 2018Inventor: Ruth KATZ
-
Patent number: 9078618Abstract: Methods and systems for patient alignment for nuclear medicine imaging are provided. One method includes activating a proximity sensor system associated with imaging detectors of the diagnostic imaging system, wherein the imaging detectors are in an L-mode configuration. The method also includes initiating movement of a patient table of the diagnostic imaging system and using a sensed proximity of a patient on the moving patient table by the proximity sensor system to automatically adjust a height of the patient table on which the patient is supported to a patient table height scanning position.Type: GrantFiled: October 29, 2010Date of Patent: July 14, 2015Assignee: General Electric CompanyInventors: Eli Stern, Deborah Ruth Zelnik, Ruth Katz
-
Publication number: 20120108952Abstract: Methods and systems for patient alignment for nuclear medicine imaging are provided. One method includes activating a proximity sensor system associated with imaging detectors of the diagnostic imaging system, wherein the imaging detectors are in an L-mode configuration. The method also includes initiating movement of a patient table of the diagnostic imaging system and using a sensed proximity of a patient on the moving patient table by the proximity sensor system to automatically adjust a height of the patient table on which the patient is supported to a patient table height scanning position.Type: ApplicationFiled: October 29, 2010Publication date: May 3, 2012Inventors: Eli Stern, Deborah Ruth Zelnik, Ruth Katz
-
Patent number: 8093001Abstract: Gene probes for specific regions of chromosome 3 (3p21.3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.Type: GrantFiled: April 15, 2010Date of Patent: January 10, 2012Assignee: Board of Regents, The University of Texas SystemInventors: Ruth Katz, Feng Jiang
-
Publication number: 20100317002Abstract: Provided is a method of identifying a genetically abnormal cell in a sputum sample, the method comprising: (a) staining a sputum sample using a morphological stain so as to identify a lower airway tract cell or lung cell in the sputum sample; and (b) staining the sputum sample using fluorescent in situ hybridization (FISH) so as to identify in the lower airway tract cell or lung cell a genetic abnormality in at least one of human chromosome 3p22.1 and 10q22-23, thereby identifying the genetically abnormal cell in the sputum sample. Also provided are methods and kits of diagnosing lung cancer by detecting a presence of genetically abnormal cells above a predetermined threshold in a sputum sample.Type: ApplicationFiled: October 6, 2008Publication date: December 16, 2010Applicant: Bioview Ltd.Inventors: Michal Daniely, Lea Madi, Tal Kaplan, Boaz Pal, Yuval Harari, Tanweer M. Zaidi, Ricardo L. Fernandez, Jinping Zhang, Ruth Katz
-
Publication number: 20100240060Abstract: Gene probes for specific regions of chromosome 3 (3p21.3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.Type: ApplicationFiled: April 15, 2010Publication date: September 23, 2010Applicant: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEMInventors: Ruth Katz, Feng Jiang
-
Patent number: 7741034Abstract: Gene probes for specific regions of chromosome 3 (3p21.3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.Type: GrantFiled: September 28, 2004Date of Patent: June 22, 2010Assignee: Board of Regents, The University of Texas SystemInventors: Ruth Katz, Feng Jiang
-
Publication number: 20070218480Abstract: Gene probes for specific regions of chromosomes 1, 3, 9, 10 and 17 are now shown to be useful in the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, to determine susceptibility to the development of smoking related cancers, to predict cancer progression and treatment efficacy, and to rule out other diseases.Type: ApplicationFiled: January 25, 2007Publication date: September 20, 2007Inventors: Ruth Katz, Feng Jiang
-
Publication number: 20060078885Abstract: Gene probes for specific regions of chromosome 3 (3p21.3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.Type: ApplicationFiled: September 28, 2004Publication date: April 13, 2006Inventors: Ruth Katz, Feng Jiang
-
Patent number: 6797471Abstract: Gene probes for specific regions of chromosome 3 (3p21.3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.Type: GrantFiled: August 6, 2001Date of Patent: September 28, 2004Assignee: Board of Regents, The University of Texas SystemInventors: Ruth Katz, Feng Jiang
-
Publication number: 20020081612Abstract: Gene probes for specific regions of chromosome 3 (3p21.3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.Type: ApplicationFiled: August 6, 2001Publication date: June 27, 2002Applicant: Board of Regents, The University of Texas SystemInventors: Ruth Katz, Feng Jiang